Tonix Pharmaceuticals Holding Corp Share Price Nasdaq
Stocks
US8902602015
Pharmaceuticals
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 08-18 | Tonix Pharmaceuticals Holding Corp. Announces Appointment of Seth Lederman as Interim Chief Medical Officer | CI |
| 08-10 | Tonix Pharmaceuticals Holding Corp., Q2 2026 Earnings Call, Aug 10, 2026 |
| Market Cap | 229M 197M 185M 170M 316M 21.68B 319M 2.19B 852M 11.11B 862M 843M 35.76B | P/E 2026 * |
-1.37x | P/E 2027 * | -2.02x |
|---|---|---|---|---|---|
| Enterprise Value | 229M 197M 185M 170M 316M 21.68B 319M 2.19B 852M 11.11B 862M 843M 35.76B | EV / Sales 2026 * |
4.17x | EV / Sales 2027 * | 2.07x |
| Free-Float |
99.84% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Tonix Pharmaceuticals Holding Corp
| Manager | Title | Age | Since |
|---|---|---|---|
Seth Lederman
CEO | Chief Executive Officer | 68 | 15/11/2007 |
Bradley Saenger
DFI | Director of Finance/CFO | 52 | 31/01/2016 |
Siobhan Fogarty
CTO | Chief Tech/Sci/R&D Officer | 57 | 03/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Seth Lederman
CHM | Chairman | 68 | 30/09/2011 |
Margaret Bell
BRD | Director/Board Member | 66 | 11/09/2017 |
Adeoye Olukotun
BRD | Director/Board Member | 81 | 04/09/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.04% | -2.51% | +57.73% | +108.15% | 1,034B | |
| +1.17% | +3.12% | +56.37% | +73.50% | 663B | |
| -0.58% | -1.02% | +22.79% | +75.58% | 462B | |
| +2.09% | -3.20% | +36.07% | +37.41% | 344B | |
| 0.00% | +3.26% | +29.76% | +46.97% | 307B | |
| +1.42% | -0.72% | +2.03% | +13.51% | 251B | |
| +0.29% | +0.86% | +54.79% | +73.00% | 239B | |
| -0.03% | -1.11% | -15.87% | -53.65% | 207B | |
| +1.08% | +2.11% | +34.17% | +97.29% | 186B | |
| Average | +0.46% | -0.70% | +30.87% | +52.42% | 410.37B | |
| Weighted average by Cap. | +0.27% | -0.84% | +39.49% | +67.86% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 55M 47.31M 44.42M 40.67M 75.85M 5.2B 76.4M 524M 204M 2.66B 207M 202M 8.57B | 111M 95.38M 89.56M 82M 153M 10.48B 154M 1.06B 412M 5.37B 416M 407M 17.28B |
| Net income | -169M -145M -136M -125M -233M -15.94B -234M -1.61B -627M -8.17B -634M -620M -26.3B | -164M -141M -133M -121M -227M -15.52B -228M -1.57B -610M -7.95B -617M -603M -25.6B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
